• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前在微针处理皮肤方面制剂工作和孔寿命的相关问题。

Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.

机构信息

University of Kentucky, College of Pharmacy, Department of Pharmaceutical Sciences, 459 Wethington Bldg, Lexington, KY 40536-0082, USA.

出版信息

Expert Opin Drug Deliv. 2010 May;7(5):617-29. doi: 10.1517/17425241003663228.

DOI:10.1517/17425241003663228
PMID:20205604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2858255/
Abstract

IMPORTANCE OF THE FIELD

The efficacy of microneedles in the area of transdermal drug delivery is well documented. Multiple studies have shown that enhancement of skin permeation by means of the creation of microscopic pores in the stratum corneum can greatly improve the delivery rates of drugs. However, skin pretreatment with microneedles is not the only factor affecting drug transport rates. Other factors, including drug formulation and rate of micropore closure, are also important for optimizing delivery by this route.

AREAS COVERED IN THIS REVIEW

This review aims to highlight work that has been done in these areas, with an emphasis on drug formulation parameters that affect transdermal flux.

WHAT THE READER WILL GAIN

This review creates an appreciation for the many factors affecting microneedle-enhanced delivery. Most results clearly indicate that microneedle skin pretreatment by itself may have different effects on drug transport depending on the formulation used, and formulation characteristics have different effects on the transport through untreated skin and microneedle-treated skin. Several formulation approaches are reported to optimize microneedle-enhanced drug delivery, including co-solvent use, vesicular, nanoparticulate and gel systems.

TAKE HOME MESSAGE

In addition to well-established factors that affect microneedle-assisted delivery (geometry, type of microneedle, etc.), formulation and pore viability are also critical factors that must be considered.

摘要

重要性领域

微针在经皮药物传递领域的功效已有充分记录。多项研究表明,通过在角质层中创建微小孔隙来增强皮肤渗透,可以大大提高药物的递送速率。然而,微针预处理并不是影响药物传输速率的唯一因素。其他因素,包括药物配方和微孔闭合率,对于通过这种途径优化递送也很重要。

本综述的重点是突出在这些领域所做的工作,重点介绍影响透皮通量的药物配方参数。

读者将获得的收益

本综述使人们对影响微针增强传递的许多因素有了更深入的了解。大多数结果清楚地表明,根据所用配方的不同,微针皮肤预处理本身可能对药物传输有不同的影响,并且配方特性对未处理皮肤和微针处理皮肤的传输有不同的影响。有几种配方方法被报道可以优化微针增强药物递送,包括共溶剂使用、囊泡、纳米颗粒和凝胶系统。

需要注意的是

除了影响微针辅助递送的既定因素(几何形状、微针类型等)外,配方和孔的活力也是必须考虑的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/680eaa2b26e6/nihms175267f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/a1ae3cd00f9e/nihms175267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/7babb2cc107d/nihms175267f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/da4353a71451/nihms175267f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/680eaa2b26e6/nihms175267f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/a1ae3cd00f9e/nihms175267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/7babb2cc107d/nihms175267f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/da4353a71451/nihms175267f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/2858255/680eaa2b26e6/nihms175267f4.jpg

相似文献

1
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.当前在微针处理皮肤方面制剂工作和孔寿命的相关问题。
Expert Opin Drug Deliv. 2010 May;7(5):617-29. doi: 10.1517/17425241003663228.
2
Advanced transdermal drug delivery system: A comprehensive review of microneedle technologies, novel designs, diverse applications, and critical challenges.先进的透皮给药系统:微针技术、新颖设计、多样应用及关键挑战的综合综述
Int J Pharm. 2025 Feb 10;670:125118. doi: 10.1016/j.ijpharm.2024.125118. Epub 2024 Dec 20.
3
Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.基于微针的药物输送的最新进展:特别强调其在儿科人群中的应用。
Eur J Pharm Biopharm. 2019 Mar;136:48-69. doi: 10.1016/j.ejpb.2019.01.005. Epub 2019 Jan 8.
4
Ex vivo evaluation of a microneedle array device for transdermal application.离体评价一种用于经皮给药的微针阵列装置。
Int J Pharm. 2015 Dec 30;496(2):351-9. doi: 10.1016/j.ijpharm.2015.09.070. Epub 2015 Oct 21.
5
Bioceramic microneedles with flexible and self-swelling substrate.具有柔性和自膨胀基底的生物陶瓷微针。
Eur J Pharm Biopharm. 2015 Aug;94:404-10. doi: 10.1016/j.ejpb.2015.06.016. Epub 2015 Jun 27.
6
A simple method of microneedle array fabrication for transdermal drug delivery.一种用于经皮药物传递的微针阵列制造的简单方法。
Drug Dev Ind Pharm. 2013 Feb;39(2):299-309. doi: 10.3109/03639045.2012.679361. Epub 2012 Apr 23.
7
Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.可生物降解聚合物微针贴片系统的制备、理化特性表征及其对高分子量治疗药物经皮渗透的增强作用评价。
AAPS PharmSciTech. 2017 Nov;18(8):2936-2948. doi: 10.1208/s12249-017-0774-5. Epub 2017 Apr 21.
8
A key role by polymers in microneedle technology: a new era.聚合物在微针技术中的关键作用:新时代。
Drug Dev Ind Pharm. 2021 Nov;47(11):1713-1732. doi: 10.1080/03639045.2022.2058531. Epub 2022 Apr 6.
9
Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation through Microneedle-Treated Skin.制剂和微针长度对经微针处理的皮肤透皮甲硝唑渗透的影响。
Pharm Res. 2024 Feb;41(2):355-363. doi: 10.1007/s11095-023-03640-8. Epub 2023 Dec 22.
10
Enhanced skin delivery of vismodegib by microneedle treatment.通过微针治疗增强维莫德吉的皮肤递送。
Drug Deliv Transl Res. 2015 Aug;5(4):407-23. doi: 10.1007/s13346-015-0241-3.

引用本文的文献

1
Industrial perspectives for personalized microneedles.个性化微针的产业前景。
Beilstein J Nanotechnol. 2023 Aug 15;14:857-864. doi: 10.3762/bjnano.14.70. eCollection 2023.
2
Three Dimensional Printing and Its Applications Focusing on Microneedles for Drug Delivery.聚焦用于药物递送的微针的三维打印及其应用
Pharmaceutics. 2023 May 25;15(6):1597. doi: 10.3390/pharmaceutics15061597.
3
Vaccine and vaccination as a part of human life: In view of COVID-19.疫苗和接种疫苗作为人类生活的一部分:以 COVID-19 为例。
Biotechnol J. 2022 Jan;17(1):e2100188. doi: 10.1002/biot.202100188. Epub 2021 Nov 21.
4
Recent Advances in Microneedle Platforms for Transdermal Drug Delivery Technologies.用于透皮给药技术的微针平台的最新进展
Polymers (Basel). 2021 Jul 22;13(15):2405. doi: 10.3390/polym13152405.
5
Micropore closure time is longer following microneedle application to skin of color.在对有色人种皮肤进行微针处理后,微孔闭合时间更长。
Sci Rep. 2020 Nov 3;10(1):18963. doi: 10.1038/s41598-020-75246-8.
6
Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications.用于糖尿病小鼠经皮胰岛素递送的溶解微针贴片:临床应用潜力
Materials (Basel). 2018 Sep 5;11(9):1625. doi: 10.3390/ma11091625.
7
Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.用于微针增强透皮给药的6-β-纳曲醇氨基酸前药的合成及其体外稳定性
Bioorg Med Chem Lett. 2014 Nov 15;24(22):5212-5. doi: 10.1016/j.bmcl.2014.09.072. Epub 2014 Oct 2.
8
Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity.细胞死亡与皮肤中抗原沉积的共定位增强了疫苗的免疫原性。
J Invest Dermatol. 2014 Sep;134(9):2361-2370. doi: 10.1038/jid.2014.174. Epub 2014 Apr 8.
9
Characterization of damaged skin by impedance spectroscopy: mechanical damage.阻抗谱法对损伤皮肤的特征分析:机械损伤。
Pharm Res. 2013 Aug;30(8):2036-49. doi: 10.1007/s11095-013-1052-1. Epub 2013 May 25.
10
Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics.离子染料通过微针处理后的皮肤的通量:分子特性的影响。
Int J Pharm. 2012 Nov 15;438(1-2):140-9. doi: 10.1016/j.ijpharm.2012.08.026. Epub 2012 Aug 30.

本文引用的文献

1
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs.经皮给予纳曲酮和无毛豚鼠经微针处理后的皮肤渗透半衰期。
J Pharm Sci. 2010 Jul;99(7):3072-80. doi: 10.1002/jps.22083.
2
Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.优化微针阵列以提高经皮给药的皮肤渗透性。
Ann N Y Acad Sci. 2009 Apr;1161:83-94. doi: 10.1111/j.1749-6632.2009.04083.x.
3
Skin barrier disruption by acetone: observations in a hairless mouse skin model.
Arch Dermatol Res. 2009 Sep;301(8):609-13. doi: 10.1007/s00403-009-0946-6. Epub 2009 Apr 7.
4
Microporation applications for enhancing drug delivery.用于增强药物递送的微穿孔应用。
Expert Opin Drug Deliv. 2009 Apr;6(4):343-54. doi: 10.1517/17425240902841935.
5
Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation.微针装置( Dermaroller)体外增强皮肤渗透作用:取决于针头尺寸和所用制剂
Eur J Pharm Sci. 2009 Mar 2;36(4-5):511-23. doi: 10.1016/j.ejps.2008.12.008. Epub 2008 Dec 25.
6
Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.优化用于透皮给药的微针阵列:扩展至微针的非方形分布
J Drug Target. 2009 Feb;17(2):108-22. doi: 10.1080/10611860802472370.
7
Transdermal drug delivery.经皮给药
Nat Biotechnol. 2008 Nov;26(11):1261-8. doi: 10.1038/nbt.1504.
8
In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.使用麦芽糖微针进行治疗性抗体的体外透皮递送。
Int J Pharm. 2009 Feb 23;368(1-2):109-15. doi: 10.1016/j.ijpharm.2008.10.008. Epub 2008 Oct 19.
9
Microneedle mediated delivery of nanoparticles into human skin.微针介导纳米颗粒递送至人体皮肤。
Int J Pharm. 2009 Jan 21;366(1-2):190-200. doi: 10.1016/j.ijpharm.2008.08.040. Epub 2008 Sep 4.
10
Micro-scale devices for transdermal drug delivery.用于经皮给药的微尺度装置。
Int J Pharm. 2008 Dec 8;364(2):227-36. doi: 10.1016/j.ijpharm.2008.08.032. Epub 2008 Aug 30.